BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38535066)

  • 1. Comparison of Disease Severity Classifications of Chronic Obstructive Pulmonary Disease: GOLD vs. STAR in Clinical Practice.
    Nishimura K; Kusunose M; Shibayama A; Nakayasu K
    Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FEV
    Bhatt SP; Nakhmani A; Fortis S; Strand MJ; Silverman EK; Sciurba FC; Bodduluri S
    Am J Respir Crit Care Med; 2023 Sep; 208(6):676-684. PubMed ID: 37339502
    [No Abstract]   [Full Text] [Related]  

  • 3. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
    Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of Airflow Obstruction Based on FEV
    Backman H; Vanfleteren LEGW; Mannino DM; Ekström M
    Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38597717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
    Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
    Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of severity of chronic obstructive pulmonary disease with health-related quality of life and six-minute walk test in a rural hospital of central India.
    Agrawal SR; Joshi R; Jain A
    Lung India; 2015; 32(3):233-40. PubMed ID: 25983408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of health status and its correlation with lung function in patients with chronic obstructive pulmonary disease: a study from a tertiary care center in north India.
    Gupta A; Garg K; Chopra V; Singh SP
    Monaldi Arch Chest Dis; 2023 Jun; 94(1):. PubMed ID: 37284775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2014 Updated GOLD Strategy: A Comparison of the Various Scenarios.
    Wilke S; Smid DE; Spruit MA; Janssen DJA; Muris JWM; van der Molen T; van den Akker M; Jones PW; Wouters EFM; Franssen FME
    Chronic Obstr Pulm Dis; 2014 Sep; 1(2):212-220. PubMed ID: 28848823
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-management interventions for people with chronic obstructive pulmonary disease.
    Schrijver J; Lenferink A; Brusse-Keizer M; Zwerink M; van der Valk PD; van der Palen J; Effing TW
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD002990. PubMed ID: 35001366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Severity as Predictor of Change in St George's Respiratory Questionnaire Scores in Trials of Long-acting Bronchodilators with COPD Patients.
    Jones PW; Gelhorn H; Karlsson N; Menjoge S; Müllerova H; Rennard SI; Tal-Singer R; Wilson H; Merrill D; Tabberer M
    Chronic Obstr Pulm Dis; 2017 Mar; 4(2):132-140. PubMed ID: 28848922
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with chronic obstructive pulmonary disease: A hospital-based study.
    Kharbanda S; Anand R
    Indian J Med Res; 2021 Apr; 153(4):459-464. PubMed ID: 34380792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
    Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classification.
    Nishimura K; Oga T; Tsukino M; Hajiro T; Ikeda A; Jones PW
    Respir Investig; 2014 Mar; 52(2):129-35. PubMed ID: 24636269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.